APITD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.183600E-01
Normal-vs-Stage2
7.657200E-01
Normal-vs-Stage3
4.229400E-01
Normal-vs-Stage4
4.274000E-01
Stage1-vs-Stage2
2.277200E-01
Stage1-vs-Stage3
1.221560E-01
Stage1-vs-Stage4
7.945600E-01
Stage2-vs-Stage3
2.288200E-01
Stage2-vs-Stage4
1.788180E-01
Stage3-vs-Stage4
1.760990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.579200E-01
Normal-vs-AfricanAmerican
4.697600E-01
Normal-vs-Asian
6.559800E-01
Caucasian-vs-AfricanAmerican
7.645000E-01
Caucasian-vs-Asian
8.031000E-01
AfricanAmerican-vs-Asian
9.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.781000E-01
Normal-vs-Female
5.186400E-01
Male-vs-Female
1.315770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.742800E-01
Normal-vs-Age(41-60Yrs)
4.909800E-01
Normal-vs-Age(61-80Yrs)
7.509200E-01
Normal-vs-Age(81-100Yrs)
6.608400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.698800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.159000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.837200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.735200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.443200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.807000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.160400E-01
Normal-vs-Daily Drinker
6.355400E-01
Normal-vs-Weekly Drinker
8.297200E-01
Normal-vs-Occasional Drinker
3.698600E-01
Normal-vs-Social Drinker
6.228000E-01
Non Drinker-vs-Daily Drinker
1.749010E-01
Non Drinker-vs-Weekly Drinker
5.428800E-01
Non Drinker-vs-Occasional Drinker
3.284200E-02
Non Drinker-vs-Social Drinker
2.419800E-01
Daily Drinker-vs-Weekly Drinker
5.508400E-01
Daily Drinker-vs-Occasional Drinker
2.145000E-01
Daily Drinker-vs-Social Drinker
8.696200E-01
Weekly Drinker-vs-Occasional Drinker
9.460500E-02
Weekly Drinker-vs-Social Drinker
5.009200E-01
Occasional Drinker-vs-Social Drinker
3.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.361400E-01
Normal-vs-Grade 2
5.842200E-01
Normal-vs-Grade 3
6.845400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.331040E-01
Grade 1-vs-Grade 3
7.668000E-02
Grade 1-vs-Grade 4
5.361400E-01
Grade 2-vs-Grade 3
4.310200E-01
Grade 2-vs-Grade 4
5.842200E-01
Grade 3-vs-Grade 4
6.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.561000E-01
Normal-vs-NonDiabetic
6.266600E-01
Diabetic-vs-NonDiabetic
1.454440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.726600E-01
Normal-vs-NoPancreatitis
6.622000E-01
Pancreatitis-vs-NoPancreatitis
4.151000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.788200E-01
Normal-vs-N1
7.488800E-01
N0-vs-N1
1.606190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.600000E-01
Normal-vs-TP53-NonMutant
4.154200E-01
TP53-Mutant-vs-TP53-NonMutant
3.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
